Illumina称中国解除进口DNA测序仪禁令——彭博社报道
Illumina Says China Removed Ban on Importing DNA Sequencers - Bloomberg.com
生物技术与制药领域的最新动态
Illumina Says China Removed Ban on Importing DNA Sequencers - Bloomberg.com
Illumina Responds to Positive Updates from Chinese Ministry of Commerce - PR Newswire
Is Agilent Technologies, Inc.'s (NYSE:A) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Bringing Industry-Relevant Lab Experience to Undergraduate Life Sciences Majors with MyGlo®
Waters Corporation (WAT) Slipped Following the Acquisition Announcement - Insider Monkey
Startup pioneers subscription service for space-based astronomy
Lonza to expand bioscience testing offering with the acquisition of Redberry - SelectScience
Waters Corporation (NYSE:WAT) Beats Q3 Sales Expectations - Yahoo Finance
10x Genomics Earnings: What To Look For From TXG - Markets Financial Content
10x Genomics Earnings: What To Look For From TXG - Yahoo Finance
Why Is Waters Corporation (WAT) Stock Soaring Today - Markets Financial Content
Why Is Waters Corporation (WAT) Stock Soaring Today - TradingView
Waters Corporation Reports Strong Q3 2025 Results - TipRanks
Waters Corporation (NYSE:WAT) Beats Q3 Sales Expectations - TradingView
Waters Corporation (WAT) Projects Q4 Revenue Increase and EPS Gr - GuruFocus
Earnings call transcript: Waters Corporation beats Q3 2025 earnings expectations - Investing.com
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold - BioSpace
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win - Fierce Pharma
Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain - Fierce Biotech